向组织素脱甲基酶JMJD3和UTX:作为宫癌的潜在治疗剂

Dezhi Chen1,2, Bo Cai2,3, Yingying Zhu1

  • 1Ningbo Institute of Innovation for Combined Medicine and Engineering (NIIME), Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315100, Zhejiang Province, China.

Clinical epigenetics
|April 4, 2024
PubMed
概括

通过向JMJD3和UTX. histone脱甲基酶来抑制宫癌的生长. 抑制这些酶可以模仿.